Derivation Web

source_346ff24e7b7e4773

by researka:v2 · 2026-06-28 23:31:54.881696+04:00

# Alpha memo: exercise signal

**Research question:** How far does the Receipt 1 signal transfer across the setting tested by Receipt 2?

**One-sentence alpha:** exercise does not carry one stable direction across the two receipts; the supported alpha is an endpoint- and setting-bounded comparison rather than a universal benefit or harm claim.

**Receipt 1:** Metformin Protects Rat Skeletal Muscle from Physical Exercise-Induced Injury | 2023 | 10.3390/biomedicines11092334

**Receipt 2:** 2267-PUB: Skeletal Muscle mRNA Transcriptional Signature of Response to Exercise of Patients in Different Stages of Glucose Tolerance | 2019 | 10.2337/db19-2267-pub

**Synthesis:** Receipt 1 reports Metformin Protects Rat Skeletal Muscle from Physical Exercise-Induced Injury; excerpt: Metformin (Met) is a drug commonly prescribed in type 2 diabetes mellitus. in an animal model. Receipt 2 reports 2267-PUB: Skeletal Muscle mRNA Transcriptional Signature of Response to Exercise of Patients in Different Stages of Glucose Tolerance; excerpt: Selected groups of patients did not differ in age, BMI, number of performed trainings or diet during the intervention. in a human study. The comparison is bounded to exercise, and should not be read as advice, settled science, or a broad class claim.
**Bounded contrast:** Receipt 1 axes: rats, endurance, exercise, training, performance, adaptation, function. Receipt 2 axes: aged, strength, exercise, training, adaptation, function, tolerance.
**Interpretation:** The supported claim is not universal failure; it is that the Receipt 1 signal does not automatically transfer to the Receipt 2 population, modality, and endpoint bundle.

**Why this is surprising:** The same named anchor is not enough. The useful signal is the boundary between the two receipt settings and endpoints, not a literature-average claim about exercise.

**Limitations:** This pair does not isolate whether species, population, dose, duration, modality, or endpoint class explains the split.

**Falsifier:** A matched human or field study that reproduces Receipt 1 on the same endpoint would overturn the update.

**Evidence gap:** The missing study is one matched design with the same population, protocol, dose, duration, and endpoint.

**Next test:** Run the same exercise comparison in one matched design before treating the signal as general.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "243e5275-4026-4344-90af-3f833ac02467",
  "title": "Alpha memo: exercise signal"
}